Evidence map›Paper›PMID 33837725›Full record

ArticleThe Journal of biological chemistry

Anti-GPR56 monoclonal antibody potentiates GPR56-mediated Src-Fak signaling to modulate cell adhesion.

Treena Chatterjee, Sheng Zhang, Tressie A Posey, Joan Jacob, Ling Wu, Wangsheng Yu, Liezl E Francisco, Qingyun J Liu, Kendra S Carmon

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Adhesion G protein-coupled receptors.Pharmacological reviews · 2026
    Review
  5. Review
  6. Article
  7. HCNS neuroscience & therapeutics · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Treena ChatterjeeThe Brown Foundation Institute of Molecular Medicine and Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Sheng ZhangThe Brown Foundation Institute of Molecular Medicine and Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Tressie A PoseyThe Brown Foundation Institute of Molecular Medicine and Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Joan JacobThe Brown Foundation Institute of Molecular Medicine and Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Ling WuThe Brown Foundation Institute of Molecular Medicine and Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Wangsheng YuThe Brown Foundation Institute of Molecular Medicine and Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Liezl E FranciscoThe Brown Foundation Institute of Molecular Medicine and Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Qingyun J LiuThe Brown Foundation Institute of Molecular Medicine and Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Kendra S CarmonThe Brown Foundation Institute of Molecular Medicine and Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA. Electronic address: Kendra.S.Carmon@uth.tmc.edu.
Brown Foundation · US

Funding

Function and mechanism of LGR4 and LGR5 in Modulation of Wnt SignalingR01GM102485 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LIU, QINGYUN · 2012 to 2020
$2.1M
Mechanisms and therapeutic targeting of colon cancer stem cell plasticityR01CA226894 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CARMON, KENDRA S. · 2018 to 2022
$1.8M
NCI NIH HHS R01 CA226894NIGMS NIH HHS R01 GM102485
6 · The paper itself

Abstract

GPR56 is a member of the adhesion G-protein-coupled receptor family shown to play important roles in cell adhesion, brain development, immune function, and tumorigenesis. GPR56 is highly upregulated in colorectal cancer and correlates with poor prognosis. Several studies have shown GPR56 couples to the Gα

Indexed as

Antibodies, MonoclonalCarcinogenesisCell AdhesionCell Line, TumorColorectal NeoplasmsFocal Adhesion Kinase 1Gene Expression Regulation, NeoplasticHumansPaxillinPhosphorylationReceptors, G-Protein-CoupledrhoA GTP-Binding ProteinSerum Response FactorSignal Transductionsrc-Family KinasesADGRG1 protein, humanAntibodies, MonoclonalFocal Adhesion Kinase 1PaxillinPTK2 protein, humanReceptors, G-Protein-CoupledrhoA GTP-Binding ProteinRHOA protein, humanSerum Response Factorsrc-Family KinasesADGRG1cell adhesioncolorectal cancer (CRC)focal adhesion kinase (Fak)GPR56G-protein-coupled receptor (GPCR)monoclonal antibodypaxillinSrc

Identifiers

PMID33837725
PMCPMC7948743
OpenAlexW3120076468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.